BetterInvesting Magazine Names ELMD Stock to Study, FIVE Undervalued
BetterInvesting Magazine's advisory committee selected Electromed as its Stock to Study and Five Below as its Undervalued Stock for early 2027.
BetterInvesting Magazine's Editorial Advisory and Securities Review Committee has designated Electromed Inc. (ELMD: NASDAQ) as its "Stock to Study" and Five Below Inc. (FIVE: NASDAQ) as its "Undervalued Stock" for the January-February 2027 issue, the Troy, Michigan-based publication announced.
The dual designation places both NASDAQ-listed companies under the scrutiny of the magazine's subscriber base, which traditionally uses the selections as a starting point for independent research rather than as direct buy recommendations. BetterInvesting has historically framed its picks as educational tools aligned with its long-term, fundamentals-driven investment philosophy.
Read more Inverse Anthropic ETFs Give Traders Bearish Options on ANT Stock →
Electromed, a medical device company, earns the "Stock to Study" label — a designation intended to highlight firms with characteristics worth deeper analysis, whether favorable or cautionary. Five Below, the discount retail chain, receives the "Undervalued Stock" designation, suggesting the committee sees its current market price as trading below intrinsic value based on its analytical framework.
The selections carry weight among the magazine's readership of individual investors and investment clubs, a community BetterInvesting has served for decades. The January-February 2027 issue is expected to include full analytical detail supporting both picks, giving readers the data needed to form their own conclusions.
Continue reading at All Financial Services & Investing.